These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9641463)

  • 21. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Bhargava HN; Ramarao P; Richter CM; Bieniarz AA
    Neuropharmacology; 1989 Jan; 28(1):63-7. PubMed ID: 2927580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H.
    Milanés MV; Rabadan JV; Marin MT; Laorden ML
    J Auton Pharmacol; 1998 Dec; 18(6):371-5. PubMed ID: 9915602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa-opioid receptors behind the blood-brain barrier are involved in the anti-hypertensive effects of systemically administered kappa-agonists in the conscious spontaneously hypertensive rat.
    Shen S; Ingenito AJ
    J Pharm Pharmacol; 1999 Nov; 51(11):1251-6. PubMed ID: 10632082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic blockade of hippocampal kappa receptors increases arterial pressure in conscious spontaneously hypertensive rats but not in normotensive Wistar Kyoto rats.
    Shen S; Ingenito AJ
    Clin Exp Hypertens; 2000 Jul; 22(5):507-19. PubMed ID: 10937841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P; Bhargava HN
    Pharmacol Biochem Behav; 1989 Jun; 33(2):375-80. PubMed ID: 2554341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCB, a novel specific kappa opioid agonist, which discriminates between opioid and sigma 1 recognition sites.
    Ronsisvalle G; Prezzavento O; Pasquinucci L; Marrazzo A; Vittorio F; Gomez-Vidal JA; Carboni L; Spampinato S
    Life Sci; 1995; 57(16):1487-95. PubMed ID: 7564893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced inhibitory actions of adenosine A1 and kappa 1-opioid receptor agonists on beta-adrenoceptors in spontaneously hypertensive rat heart.
    Yu XC; Wang HX; Wong TM
    Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):976-7. PubMed ID: 9406669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
    Ohno M; Yamamoto T; Araki H; Ueki S
    Psychopharmacology (Berl); 1987; 91(2):189-92. PubMed ID: 3107029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
    Friese N; Chevalier E; Angel F; Pascaud X; Junien JL; Dahl SG; Riviere PJ
    Life Sci; 1997; 60(9):625-34. PubMed ID: 9048965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.